These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23698116)

  • 1. Chronic effects of dietary vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease.
    Rangan GK; Schwensen KG; Foster SL; Korgaonkar MS; Peduto A; Harris DC
    Am J Physiol Renal Physiol; 2013 Aug; 305(4):F574-82. PubMed ID: 23698116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D deficiency: a nontraditional risk factor in polycystic kidney disease?
    Reed-Gitomer B
    Am J Physiol Renal Physiol; 2013 Oct; 305(7):F975-6. PubMed ID: 23804446
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease.
    Sagar PS; Zhang J; Luciuk M; Mannix C; Wong ATY; Rangan GK
    PLoS One; 2019; 14(1):e0209186. PubMed ID: 30601830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dimethyl fumarate on renal disease progression in a genetic ortholog of nephronophthisis.
    Oey O; Rao P; Luciuk M; Mannix C; Rogers NM; Sagar P; Wong A; Rangan G
    Exp Biol Med (Maywood); 2018 Mar; 243(5):428-436. PubMed ID: 29436846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
    Ding A; Kalaignanasundaram P; Ricardo SD; Abdelkader A; Witting PK; Broughton BR; Kim HB; Wyse BF; Phillips JK; Evans RG
    Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):917-29. PubMed ID: 23006058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of an observational study to determine the effects of cholecalciferol on hypertension, proteinuria and urinary MCP-1 in ADPKD.
    Rangan GK; Harris DC
    Curr Hypertens Rev; 2013 May; 9(2):115-20. PubMed ID: 23971693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine dithiocarbamate reduces the progression of total kidney volume and cyst enlargement in experimental polycystic kidney disease.
    Ta MH; Rao P; Korgaonkar M; Foster SF; Peduto A; Harris DC; Rangan GK
    Physiol Rep; 2014 Dec; 2(12):. PubMed ID: 25501440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease.
    Ta MH; Schwensen KG; Foster S; Korgaonkar M; Ozimek-Kulik JE; Phillips JK; Peduto A; Rangan GK
    PLoS One; 2016; 11(10):e0164193. PubMed ID: 27723777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E ameliorates renal injury in an experimental model of immunoglobulin A nephropathy.
    Trachtman H; Chan JC; Chan W; Valderrama E; Brandt R; Wakely P; Futterweit S; Maesaka J; Ma C
    Pediatr Res; 1996 Oct; 40(4):620-6. PubMed ID: 8888293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D deficiency contributes to vascular damage in sustained ischemic acute kidney injury.
    de Bragança AC; Volpini RA; Mehrotra P; Andrade L; Basile DP
    Physiol Rep; 2016 Jul; 4(13):. PubMed ID: 27369932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
    Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease.
    Oksa A; Spustová V; Krivosíková Z; Gazdíková K; Fedelesová V; Lajdová I; Stefíková K; Bernasovská G; Zilinská Z; Dzúrik R
    Kidney Blood Press Res; 2008; 31(5):322-9. PubMed ID: 18802363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the dietary delivery matrix on vitamin D3 bioavailability and bone mineralisation in vitamin-D3-deficient growing male rats.
    Hodgkinson AJ; Wallace OAM; Kruger MC; Prosser CG
    Br J Nutr; 2018 Jan; 119(2):143-152. PubMed ID: 29268806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease.
    Harrison JL; Hildreth CM; Callahan SM; Goodchild AK; Phillips JK
    Auton Neurosci; 2010 Jan; 152(1-2):60-6. PubMed ID: 19825515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
    Agarwal R
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Vitamin D on the Vasoactive Effect of Estradiol in a Rat Model of Polycystic Ovary Syndrome.
    Tarszabó R; Bányai B; Ruisanchez É; Péterffy B; Korsós-Novák Á; Lajtai K; Sziva RE; Gerszi D; Hosszú Á; Benkő R; Benyó Z; Horváth EM; Masszi G; Várbíró S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.